Skip to main content
Clinical Trials/NCT06533904
NCT06533904
Not yet recruiting
Not Applicable

Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures

Loma Linda University1 site in 1 country30 target enrollmentSeptember 1, 2026

Overview

Phase
Not Applicable
Intervention
Multi-modal pain regimen
Conditions
Trauma
Sponsor
Loma Linda University
Enrollment
30
Locations
1
Primary Endpoint
Rate of abnormal respiratory mechanics: Incentive Spirometry
Status
Not yet recruiting
Last Updated
2 months ago

Overview

Brief Summary

The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are:

Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cryoablation improve short and long term respiratory mechanics? Does percutaneous cryoablation improve long term quality of life? Does percutaneous cryoablation decrease delirium?

Researchers will compare cryoablation to standard multimodal pain therapy to see if this impacts respiratory recovery.

Participants will undergo randomization, percutaneous cryoablative procedure, and participate in tests at pre-determined intervals to evaluate their pulmonary recovery.

Registry
clinicaltrials.gov
Start Date
September 1, 2026
End Date
July 1, 2028
Last Updated
2 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • \> 18 years old
  • \> 2 rib fractures
  • Verbal Pain score \> 5
  • Incentive Spirometry \< 60% of predicted

Exclusion Criteria

  • Isolated Fractures of Ribs 1-3 and/or 10-12
  • Posterior Rib Fracture \< 4 cm from costovertebral joint
  • Sternal, Clavicle, Scapula Fracture
  • Thoracic Spinal Fracture of any type
  • Open Abdominothoracic Surgery
  • Unstable Spine
  • Extensive Subcutaneous Emphysema
  • BMI \> 35
  • Plan for Rib Plating
  • Chronic Opioid Use

Arms & Interventions

Standard multi-modal pain regimen alone

Intervention: Multi-modal pain regimen

Standard multi-modal pain regimen with percutaneous cryoablation

Intervention: Percutaneous Cryoablation of Intercostal Nerves

Standard multi-modal pain regimen with percutaneous cryoablation

Intervention: Multi-modal pain regimen

Outcomes

Primary Outcomes

Rate of abnormal respiratory mechanics: Incentive Spirometry

Time Frame: Through study completion, up to 1 year

Pain Score: Numeric Pain Scale

Time Frame: Through study completion, up to 1 year

Short and Long Term Pain Scores. Range from 0 to 10 where 0 is no pain and 10 is most severe and worse outcome.

Rate of delirium: Confusion Assessment Method (CAM) Score

Time Frame: Through study completion, up to 1 year

The score ranges from 0 to 19. Where higher scores indicate more severe delirium and low scores indicate less severe or no delirium

Rate of abnormal respiratory mechanics: Pulmonary Function Tests

Time Frame: Through study completion, up to 1 year

Short and Long Term Respiratory Mechanics. Pulmonary Function Tests will specifically measure Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC)

Quality of Life on Survey

Time Frame: Through study completion, up to 1 year

Long Term Quality of Life

Secondary Outcomes

  • Rate of need for tracheostomy(Through study completion, up to 1 year)
  • ICU Length of Stay(Through study completion, up to 1 year)
  • Acute Respiratory Distress Syndrome(Through study completion, up to 1 year)
  • Rate of Pneumonia(Through study completion, up to 1 year)
  • Rate of need for Intubation/Mechanical Ventilation(Through study completion, up to 1 year)
  • Hospital Length of Stay(Through study completion, up to 1 year)
  • Number of Ventilatory Days(Through study completion, up to 1 year)
  • Rate of Mortality(Through study completion, up to 1 year)
  • Rate of Pleural Space Complications(Through study completion, up to 1 year)

Study Sites (1)

Loading locations...

Similar Trials